BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11711902)

  • 1. Comparison between rest technetium-99m-tetrofosmin and rest-redistribution thallium-201 SPECT in stable patients with healed myocardial infarction.
    Kula M; Tutus A; Abaci A; Oguzhan A; Arslan SM; Ergin A
    Nucl Med Commun; 2001 Dec; 22(12):1317-24. PubMed ID: 11711902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion to detect severely ischaemic but viable myocardium: a comparative study with thallium-201.
    Kula M; Tutuş A; Unal S; Topsakal R; Ergin A
    Nucl Med Commun; 2003 Sep; 24(9):987-94. PubMed ID: 12960598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise-test Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjection.
    Nicolai E; Cuocolo A; Acampa W; Varrone A; Pace L; Salvatore M
    J Nucl Cardiol; 1999; 6(3):270-7. PubMed ID: 10385182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with rest-redistribution thallium-201.
    Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Yamamoto S; Tonami N
    J Am Coll Cardiol; 1997 May; 29(6):1226-33. PubMed ID: 9137217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
    Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
    Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease.
    Shanoudy H; Raggi P; Beller GA; Soliman A; Ammermann EG; Kastner RJ; Watson DD
    J Am Coll Cardiol; 1998 Feb; 31(2):331-7. PubMed ID: 9462576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and Tl-201 scintigraphy.
    Acampa W; Cuocolo A; Petretta M; Bruno A; Castellani M; Finzi A; Gerundini P
    J Nucl Cardiol; 2002; 9(1):33-40. PubMed ID: 11845127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery.
    Sciagrà R; Bisi G; Santoro GM; Zerauschek F; Sestini S; Pedenovi P; Pappagallo R; Fazzini PF
    J Am Coll Cardiol; 1997 Aug; 30(2):384-91. PubMed ID: 9247509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography.
    Flotats A; Carrió I; Estorch M; Bernà L; Catafau AM; Marí C; Ballester M
    Eur J Nucl Med; 1997 Jul; 24(7):767-73. PubMed ID: 9211763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction.
    Galassi AR; Tamburino C; Grassi R; Foti R; Mammana C; Virgilio A; Licciardello G; Musumeci S; Giuffrida G
    J Nucl Cardiol; 1998; 5(1):56-63. PubMed ID: 9504874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse redistribution phenomenon on rest (99m)Tc-tetrofosmin myocardial single photon emission computed tomography involves impaired left ventricular contraction in patients with acute myocardial infarction.
    Kurokawa K; Ohte N; Miyabe H; Akita S; Yajima K; Hayano J; Kimura G
    Circ J; 2003 Oct; 67(10):830-4. PubMed ID: 14578614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.
    Maruyama A; Hasegawa S; Paul AK; Xiuli M; Yoshioka J; Maruyama K; Hori M; Nishimura T
    Ann Nucl Med; 2002 Feb; 16(1):25-32. PubMed ID: 11922205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging.
    Giorgetti A; Marzullo P; Sambuceti G; Di Quirico S; Kusch A; Landi P; Salvadori PA; Pisani P; L'abbate A
    J Nucl Cardiol; 2004; 11(2):142-51. PubMed ID: 15052245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between reverse redistribution of 99mTc-tetrofosmin in sub-acute phase and left ventricular functional recovery in chronic phase in patients with acute myocardial infarction.
    Fujiwara S; Shiotani H; Kawai H; Kudoh H; Shite J; Hirata K
    Ann Nucl Med; 2009 Dec; 23(10):863-8. PubMed ID: 19921352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
    Caner B; Beller GA
    Clin Cardiol; 1998 Apr; 21(4):235-42. PubMed ID: 9562932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease.
    Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Ichiyanagi K; Hisada K
    J Nucl Med; 1995 Nov; 36(11):1961-7. PubMed ID: 7472582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of rest-redistribution thallium-201 imaging and reinjection after stress-redistribution for the assessment of myocardial viability in patients with left ventricular dysfunction secondary to coronary artery disease.
    Galassi AR; Centamore G; Fiscella A; Coppola A; Liberti F; Franco M; Palazzo G; Musumeci S; Galassi A
    Am J Cardiol; 1995 Mar; 75(7):436-42. PubMed ID: 7863985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease.
    Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Tonami N; Hisada K
    Am J Cardiol; 1996 Feb; 77(5):350-4. PubMed ID: 8602561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction.
    Cuocolo A; Acampa W; Nicolai E; Pace L; Petretta M; Salvatore M
    J Nucl Cardiol; 2000; 7(1):8-15. PubMed ID: 10698229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study.
    Kapur A; Latus KA; Davies G; Dhawan RT; Eastick S; Jarritt PH; Roussakis G; Young MC; Anagnostopoulos C; Bomanji J; Costa DC; Pennell DJ; Prvulovich EM; Ell PJ; Underwood SR
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1608-16. PubMed ID: 12458395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.